950220

692 KRW
26
3.62%
Last update Dec 12, 3:00 PM KST
Market closed
Day range
680
749
Previous close
718
Open
722
Access this stock data via API
Subscribe
NeoImmuneTech, Inc.
692.00
26
3.62%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 170.4M
Cost of revenue
Gross profit 170.4M
Operating expense
Research & development 38.4B
Selling general and admin 21.5B 29.5B 37.0B 31.7B
Other operating expenses
Operating income -40.0B -55.6B -58.2B -51.9B
Non operating interest income
Income 1.8B 2.9B 1.2B 390.9M
Expense 726.1M 225.3M 261.4M 219.2M
Other income expense
Pretax income -40.9B -53.3B -60.3B -52.4B
Tax provision 12.8M 101.3M 116.4M 69.5M
Net income -40.9B -53.4B -60.4B -52.5B
Basic EPS -2.1K -2.7K -3.1K -2.8K
Diluted EPS -2.1K -2.7K -3.1K -2.8K
Basic average shares 19.7M 19.8M 19.7M 19.0M
Diluted average shares 19.7M 19.8M 19.7M 19.0M
EBITDA -36.5B -49.6B -57.2B -50.2B
Net income from continuing op. -44.1B -52.7B -59.3B -54.4B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 4 hours 44 minutes

02:45
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:30 - 09:00
Main market
09:00 - 15:30
Post-market
15:30 - 18:00
All times are displayed in the Asia/Seoul timezone (KST, UTC+09:00).